Ruffo Frank 4
4 · Aclaris Therapeutics, Inc. · Filed Feb 11, 2022
Insider Transaction Report
Form 4
Ruffo Frank
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-02-09$12.66/sh−1,388$17,568→ 172,359 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on February 1, 2022 pursuant to preexisting sell-to-cover elections.